Literature DB >> 15349808

Alcohol and iron.

Anthony S Tavill1, Asif M Qadri.   

Abstract

Iron in its free ferrous and ferric states may serve as a physiological regulator of normal intracellular functions but can be a double-edged sword when linked to several pathways of cellular toxicity. In particular, oxidative stress-induced cytotoxicity leading to both necrosis and apoptosis (so-called necrapoptosis) may be promoted by increased intracellular free iron. When hepatocyte iron accumulates to excess in clinical alcohol abuse or in an experimental, combined model of iron and alcohol hepatotoxicity, there is evidence for synergy among the putative pathways of oxidative stress. Just how excess hepatocyte iron accumulates in alcohol excess is unknown, but when the usual safe harbor for intracellular iron, namely the endosomal-lysosomal compartment, is compromised, it becomes a potent source of free, chelatable pro-oxidant iron. In this regard excess iron in alcohol-induced liver damage and alcohol excess in iron-overload disease are powerful cocktails promoting subcellular organelle damage leading to cell death and fibrogenesis. In some experimental circumstances, only the combined insults of both alcohol and iron overload are capable of inducing cell injury and fibrogenesis. There are clinical examples for such relative resistance to each hepatotoxin presented to the liver in isolation that lend support to this concept of synergy of pro-oxidant pathways of liver injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349808     DOI: 10.1055/s-2004-832943

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  14 in total

1.  Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.

Authors:  Mark Thursz
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

Review 2.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

3.  Down-regulation of hepcidin in porphyria cutanea tarda.

Authors:  Richard S Ajioka; John D Phillips; Robert B Weiss; Diane M Dunn; Maria W Smit; Sean C Proll; Michael G Katze; James P Kushner
Journal:  Blood       Date:  2008-09-22       Impact factor: 22.113

4.  HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.

Authors:  Yan-Yan Xu; Yu-Han Tang; Xiao-Ping Guo; Jing Wang; Ping Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

5.  Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.

Authors:  Tsung-Jung Lin; Li-Ying Liao; Shyr-Yi Lin; Chih-Lin Lin; Ting-An Chang
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  Medical Care of the Patient With Compensated Cirrhosis.

Authors:  Jorge L Herrera; Reynaldo Rodríguez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-02

7.  Gender-related variations in iron metabolism and liver diseases.

Authors:  Duygu D Harrison-Findik
Journal:  World J Hepatol       Date:  2010-08-27

Review 8.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 9.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 10.  Current experimental perspectives on the clinical progression of alcoholic liver disease.

Authors:  Katja Breitkopf; Laura E Nagy; Juliane I Beier; Sebastian Mueller; Honglei Weng; Steven Dooley
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.